AmitM, CollinsMT, FitzGibbonEJ, ButmanJA, FlissDM, GilZ. Surgery versus watchful waiting in patients with craniofacial fibrous dysplasia--a meta-analysis.PLoS One.2011;6:e25179. [PMC free article: PMC3179490] [PubMed: 21966448]
BerglundJA, TellaSH, TuthillKF, KimL, GuthrieLC, PaulSM, StantonR, CollinsMT, BoyceAM. Scoliosis in fibrous dysplasia/McCune-Albright syndrome: factors associated with curve progression and effects of bisphosphonates.J Bone Miner Res.2018;33:1641-8. [PubMed: 29669167]
BhattacharyyaN, WienchM, DumitrescuC, ConnollyBM, BuggeTH, PatelHV, GafniRI, ChermanN, ChoM, HagerGL, CollinsMT. Mechanism of FGF23 processing in fibrous dysplasia.J Bone Miner Res.2012;27: 1132-41. [PMC free article: PMC7448291] [PubMed: 22247037]
BiancoP, RiminucciM, MajolagbeA, KuznetsovSA, CollinsMT, MankaniMH, CorsiA, BoneHG, WientroubS, SpiegelAM, FisherLW, RobeyPG. Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone.J Bone Miner Res.2000; 15:120-8. [PubMed: 10646121]
BiazzoA, Di BernardoA, ParafioritiA, ConfalonieriN. Mazabraud syndrome associated with McCune-Albright syndrome: a case report and review of the literature.Acta Biomed.2017;88:198-200. [PMC free article: PMC6166146] [PubMed: 28845837]
BoyceAM, BrewerC, DeKlotzTR, ZalewskiCK, KingKA, CollinsMT, KimHJ. Association of hearing loss and otologic outcomes with fibrous dysplasia.JAMA Otolaryngol Head Neck Surg.2018;144:102-7 [PMC free article: PMC5839293] [PubMed: 29192304]
BoyceAM, CaseyRK, Ovejero CrespoD, EstradaA, GuthrieLC, BrillanteBA, Gomez-LoboV, NiemanLK, CollinsMT. Gynecologic and obstetrical outcomes in fibrous dysplasia/McCune-Albright syndrome.Orphanet J Rare Dis.2019;14:90. [PMC free article: PMC6489337] [PubMed: 31036049]
BoyceAM, ChongWH, ShawkerTH, PintoPA, LinehanWM, BhattacharryyaN, MerinoMJ, SingerFR, CollinsMT. Characterization and management of testicular pathology in McCune-Albright syndrome.J Clin Endocrinol Metab.2012a;97: E1782-90. [PMC free article: PMC3431566] [PubMed: 22745241]
BoyceAM, ChongWH, YaoJ, GafniRI, KellyMH, ChamberlainCE, BassimC, ChermanN, EllsworthM, Kasa-VubuJZ, FarleyFA, MolinoloAA, BhattacharyyaN, CollinsMT. Denosumab treatment for fibrous dysplasia.J Bone Miner Res.2012b;27:1462-70. [PMC free article: PMC3377825] [PubMed: 22431375]
BoyceAM, GloverM, KellyMH, BrillanteBA, ButmanJA, FitzgibbonEJ, BrewerCC, ZalewskiCK, Cutler PeckCM, KimHJ, CollinsMT. Optic neuropathy in McCune-Albright syndrome: effects of early diagnosis and treatment of growth hormone excess.J Clin Endocrinol Metab.2013;98:E126-34. [PMC free article: PMC3537097] [PubMed: 23093488]
BoyceAM, KellyMH, BrillanteBA, KushnerH, WientroubS, RiminucciM, BiancoP, RobeyPG, CollinsMT. A randomized, double blind, placebo-controlled trial of alendronate treatment for fibrous dysplasia of bone.J Clin Endocrinol Metab.2014;99:4133-40. [PMC free article: PMC4223439] [PubMed: 25033066]
BoyceAM, TurnerA, WattsL, Forestier-ZhangL, UnderhillA, Pinedo-VillanuevaR, MonsellF, TessarisD, BurrenC, MasiL, HamdyN, BrandiML, ChapurlatR, CollinsMT, JavaidMK. Improving patient outcomes in fibrous dysplasia/McCune-Albright syndrome: an international multidisciplinary workshop to inform an international partnership.Arch Osteoporos.2017;12:21. [PMC free article: PMC5653227] [PubMed: 28243882]
BrownRJ, KellyMH, CollinsMT. Cushing syndrome in the McCune-Albright syndrome.J Clin Endocrinol Metab.2010; 95:1508-15. [PMC free article: PMC2853983] [PubMed: 20157193]
CarneyJA, YoungWF, StratakisCA. Primary bimorphic adrenocortical disease: cause of hypercortisolism in McCune-Albright syndrome.Am J Surg Pathol.2011;35:1311-26. [PMC free article: PMC4140081] [PubMed: 21836496]
CeliFS, CoppotelliG, ChidakelA, KellyM, BrillanteBA, ShawkerT, ChermanN, FeuillanPP, CollinsMT. The role of type 1 and type 2 5'-deiodinase in the pathophysiology of the 3,5,3'-triiodothyronine toxicosis of McCune-Albright syndrome.J Clin Endocrinol Metab.2008;93:2383-9. [PMC free article: PMC2435649] [PubMed: 18349068]
ClarkTJ, TanBK, KennedyCR. Asynchronous ovarian torsion in a patient with McCune-Albright syndrome.J Obstet Gynaecol.2000;20:204. [PubMed: 15512529]
CollinsMT, ChebliC, JonesJ, KushnerH, ConsugarM, RinaldoP, WientroubS, BiancoP, RobeyPG. Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia.J Bone Miner Res.2001;16:806-13. [PubMed: 11341325]
CollinsMT, KushnerH, ReynoldsJC, ChebliC, KellyMH, GuptaA, BrillanteB, LeetAI, RiminucciM, RobeyPG, BiancoP, WientroubS, ChenCC. An instrument to measure skeletal burden and predict functional outcome in fibrous dysplasia of bone.J Bone Miner Res.2005;20:219-26. [PubMed: 15647815]
CollinsMT, SarlisNJ, MerinoMJ, MonroeJ, CrawfordSE, KrakoffJA, GuthrieLC, BonatS, RobeyPG, ShenkerA. Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations.J Clin Endocrinol Metab.2003;88:4413-7. [PubMed: 12970318]
CollinsMT, SingerFR, EugsterE. McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasia.Orphanet J Rare Dis.2012;7:S4. [PMC free article: PMC3359955] [PubMed: 22640971]
CutlerCM, LeeJS, ButmanJA, FitzGibbonEJ, KellyMH, BrillanteBA, FeuillanP, RobeyPG, DuFresneCR, CollinsMT. Long-term outcome of optic nerve encasem*nt and optic nerve decompression in patients with fibrous dysplasia: risk factors for blindness and safety of observation.Neurosurgery.2006;59:1011-7. [PubMed: 17143235]
de CastroLF, BurkeAB, WangHD, TsaiJ, FlorenzanoP, PanKS, BhattacharyyaN, BoyceAM, GafniRI, MolinoloAA, RobeyPG, CollinsMT. Activation of RANK/RANKL/OPG pathway is involved in the pathophysiology of fibrous dysplasia and associated with disease burden.J Bone Miner Res.2019;34:290-4. [PMC free article: PMC6983320] [PubMed: 30496606]
de CastroLF, MichelZ, PanK, TaylorJ, SzymczukV, ParavastuS, SabouryB, PapadakisGZ, LiX, MilliganK, BoyceB, PaulSM, CollinsMT, BoyceAM. Safety and efficacy of denosumab for fibrous dysplasia of bone.New Eng J Med.2023;388:766–8. [PMC free article: PMC10015375] [PubMed: 36812441]
de CastroLF, OvejeroD, BoyceAM. DIAGNOSIS OF ENDOCRINE DISEASE: Mosaic disorders of FGF23 excess: fibrous dysplasia/McCune-Albright syndrome and cutaneous skeletal hypophosphatemia syndrome.Eur J Endocrinol.2020;182:R83-R99. [PMC free article: PMC7104564] [PubMed: 32069220]
de SanctisL, GallianoI, MontanariP, MatarazzoP, TessarisD, BergalloM.Combining real-time COLD- and MAMA-PCR TaqMan techniques to detect and quantify R201 GNAS mutations in the McCune-Albright syndrome.Horm Res Paediatr.2017;87:342-9. [PubMed: 28334704]
EstradaA, BoyceAM, BrillanteBA, GuthrieLC, GafniRI, CollinsMT. Long-term outcomes of letrozole treatment for precocious puberty in girls with McCune-Albright syndrome.Eur J Endocrinol.2016;175:477-83. [PMC free article: PMC5066167] [PubMed: 27562402]
EugsterEA, RubinSD, ReiterEO, PlourdeP, JouHC, PescovitzOH; McCune-Albright Study Group. Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial.J Pediatr.2003;143:60-6. [PubMed: 12915825]
FeuillanP, CalisK, HillS, ShawkerT, RobeyPG, CollinsMT. Letrozole treatment of precocious puberty in girls with the McCune-Albright syndrome: a pilot study.J Clin Endocrinol Metab.2007;92:2100-6. [PubMed: 17405850]
GaujouxS, SalenaveS, RonotM, RangheardAS, CrosJ, BelghitiJ, SauvanetA, RuszniewskiP, ChansonP. Hepatobiliary and pancreatic neoplasms in patients with McCune-Albright syndrome.J Clin Endocrinol Metab.2014;99:E97-101. [PubMed: 24170100]
GeelsRES, MeierME, SaikaliA, TsonakaR, Appelman-DijkstraNM, BoyceAM. Long bone fractures in fibrous dysplasia/McCune-Albright syndrome: prevalence, natural history, and risk factors.J Bone Miner Res.2022;37:236-43. [PMC free article: PMC9548190] [PubMed: 34668234]
GladdingA, SzymczukV, AubleBA, BoyceAM. Burosumab treatment for fibrous dysplasia.Bone.2021;150:116004. [PMC free article: PMC8272883] [PubMed: 33984553]
Hagelstein-RotmanM, MeierME, MajoorBCJ, ClevenAHG, DijkstraPDS, HamdyNAT, van de SandeMAJ, DekkersOM, Appelman-DijkstraNM. Increased prevalence of malignancies in fibrous dysplasia/McCune-Albright syndrome (FD/MAS): data from a national referral center and the Dutch National Pathology Registry (PALGA).Calcif Tissue Int.2021;108:346-53. [PubMed: 33226445]
HansenMR, MoffatJC. Osteosarcoma of the skull base after radiation therapy in a patient with McCune-Albright syndrome: case report.Skull Base.2003;13:79-83. [PMC free article: PMC1131834] [PubMed: 15912163]
HartES, KellyMH, BrillanteB, ChenCC, ZiranN, LeeJS, FeuillanP, LeetAI, KushnerH, RobeyPG, CollinsMT. Onset, progression, and plateau of skeletal lesions in fibrous dysplasia and the relationship to functional outcome.J Bone Miner Res.2007;22:1468-74. [PubMed: 17501668]
HuangSJ, AmendolaLM, SternenDL. Variation among DNA banking consent forms: points for clinicians to bank on.J Community Genet.2022;13:389-97. [PMC free article: PMC9314484] [PubMed: 35834113]
IdowuBD, Al-AdnaniM, O'DonnellP, YuL, OdellE, DissT, GaleRE, FlanaganAM. A sensitive mutation-specific screening technique for GNAS1 mutations in cases of fibrous dysplasia: the first report of a codon 227 mutation in bone.Histopathology.2007;50:691-704. [PubMed: 17493233]
IkawaY, YachiY, InoueN, KatoA, OkajimaM, YachieA.Neonatal McCune-Albright syndrome with giant cell hepatitis.J Pediatr.2016;178:298. [PubMed: 27592093]
JavaidMK, BoyceA, Appelman-DijkstraN, OngJ, DefabianisP, OffiahA, ArundelP, ShawN, PosVD, UnderhilA, PorteroD, HeralL, HeegaardAM, MasiL, MonsellF, StantonR, DijkstraPDS, BrandiML, ChapurlatR, HamdyNAT, CollinsMT. Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium.Orphanet J Rare Dis.2019Jun;14:139. [PMC free article: PMC6567644] [PubMed: 31196103]
JohansenL, HallerW, ThyagarajanM, KellyD, McKiernanP. Hepatic lesions associated with McCune Albright syndrome.J Pediatr Gastroenterol Nutr.2019;68:e54-e57. [PubMed: 30628989]
KalfaN, PhilibertP, AudranF, EcochardA, HannonT, LumbrosoS, SultanC. Searching for somatic mutations in McCune-Albright syndrome: a comparative study of the peptidic nucleic acid versus the nested PCR method based on 148 DNA samples.Eur J Endocrinol.2006;155:839-43. [PubMed: 17132753]
KatznelsonL, LawsERJr, MelmedS, MolitchME, MuradMH, UtzA, WassJA. Acromegaly: an endocrine society clinical practice guideline.J Clin Endocrinol Metab.2014;99:3933-51. [PubMed: 25356808]
KellyMH, BrillanteB, CollinsMT. Pain in fibrous dysplasia of bone: age-related changes and the anatomical distribution of skeletal lesions.Osteoporos Int.2008;19:57-63. [PubMed: 17622477]
KellyMH, BrillanteB, KushnerH, Gehron RobeyP, CollinsMT. Physical function is impaired but quality of life preserved in patients with fibrous dysplasia of bone.Bone.2005;37:388-94. [PubMed: 15963775]
KonradiA.Assessing quality of life in pediatric fibrous dysplasia and McCune Albright syndrome: PEDS-QL and HADS data from the Fibrous Dysplasia Foundation Patient Registry.J Patient Rep Outcomes.2021;5:34. [PMC free article: PMC8042095] [PubMed: 33846865]
KuznetsovSA, ChermanN, RiminucciM, CollinsMT, RobeyPG, BiancoP. Age-dependent demise of GNAS-mutated skeletal stem cells and "normalization" of fibrous dysplasia of bone.J Bone Miner Res.2008;23:1731-40. [PMC free article: PMC2585500] [PubMed: 18597624]
LalaR, AndreoM, PucciA, MatarazzoP. Persistent hyperestrogenism after precocious puberty in young females with McCune-Albright syndrome.Pediatr Endocrinol Rev.2007;4Suppl 4:423-8. [PubMed: 17982390]
LandisCA, MastersSB, SpadaA, PaceAM, BourneHR, VallarL. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.Nature.1989;340:692-6. [PubMed: 2549426]
LawlessST, ReevesG, BowenJR. The development of thyroid storm in a child with McCune-Albright syndrome after orthopedic surgery.Am J Dis Child.1992;146:1099-102. [PubMed: 1514560]
LeeJS, FitzGibbonE, ButmanJA, DufresneCR, KushnerH, WientroubS, RobeyPG, CollinsMT. Normal vision despite narrowing of the optic canal in fibrous dysplasia.N Engl J Med.2002;347:1670-6. [PubMed: 12444181]
LeeJS, FitzGibbonEJ, ChenYR, KimHJ, LustigLR, AkintoyeSO, CollinsMT, KabanLB. Clinical guidelines for the management of craniofacial fibrous dysplasia.Orphanet J Rare Dis.2012;7Suppl 1:S2. [PMC free article: PMC3359960] [PubMed: 22640797]
LeetAI, BoyceAM, IbrahimKA, WientroubS, KushnerH, CollinsMT. Bone-grafting in polyostotic fibrous dysplasia.J Bone Joint Surg Am.2016;98:211-9. [PMC free article: PMC4732545] [PubMed: 26842411]
LeetAI, ChebliC, KushnerH, ChenCC, KellyMH, BrillanteBA, RobeyPG, BiancoP, WientroubS, CollinsMT. Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome.J Bone Miner Res.2004a;19:571–7. [PubMed: 15005844]
LeetAI, MagurE, LeeJS, WientroubS, RobeyPG, CollinsMT. Fibrous dysplasia in the spine: prevalence of lesions and association with scoliosis.J Bone Joint Surg Am.2004b;86:531–7. [PubMed: 14996879]
LimYH, OvejeroD, SugarmanJS, DeklotzCM, MaruriA, EichenfieldLF, KelleyPK, JüppnerH, GottschalkM, TifftCJ, GafniRI, BoyceAM, CowenEW, BhattacharyyaN, GuthrieLC, GahlWA, GolasG, LoringEC, OvertonJD, ManeSM, LiftonRP, LevyML, CollinsMT, ChoateKA. Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia.Hum Mol Genet.2014;23:397-407. [PMC free article: PMC3869357] [PubMed: 24006476]
LiuF, LiW, YaoY, LiG, YangY, DouW, ZhongD, WangL, ZhuX, HuH, ZhangJ, WangR, ChenG.A case of McCune-Albright syndrome associated with pituitary GH adenoma: therapeutic process and autopsy.J Pediatr Endocrinol Metab.2011;24:283-7. [PubMed: 21823524]
LumbrosoS, ParisF, SultanC, European Collaborative Study. Activating Gsalpha mutations: analysis of 113 patients with signs of McCune-Albright syndrome--a European Collaborative Study.J Clin Endocrinol Metab.2004;89:2107-13. [PubMed: 15126527]
MahdiAJ, ConnorP, ThakurI. McCune-Albright syndrome-associated bone marrow failure and extramedullary haematopoeisis secondary to fibrous dysplasia.Br J Haematol.2017;178:179. [PubMed: 28612379]
MajoorBC, BoyceAM, BovéeJV, SmitVT, CollinsMT, Cleton-JansenAM, DekkersOM, HamdyNA, DijkstraPS, Appelman-DijkstraNM. Increased risk of breast cancer at a young age in women with fibrous dysplasia.J Bone Miner Res.2018a;33:84-90 [PubMed: 28856726]
MajoorBCJ, AndelaCD, QuispelCR, Rotman M2, Dijkstra PDS, Hamdy NAT, Kaptein AA, Appelman-Dijkstra NM. Illness perceptions are associated with quality of life in patients with fibrous dysplasia.Calcif Tissue Int.2018b;102:23-31 [PMC free article: PMC5760610] [PubMed: 29022055]
MajoorBCJ, PapapoulosSE, DijkstraPDS, FioccoM, HamdyNAT, Appelman-DijkstraNM. Denosumab in patients with fibrous dysplasia previously treated with bisphosphonates.J Clin Endocrinol Metab.2019a;104:6069-78. [PubMed: 31390018]
MajoorBCJ, van de SandeMAJ, Appelman-DijkstraNM, LeithnerA, JuttePC, VélezR, PerlakyT, StaalsEL, BovéeJVMG, HamdyNAT, DijkstraSPD. Prevalence and clinical features of Mazabraud syndrome: a multicenter European study.J Bone Joint Surg Am.2019b;101:160-8. [PubMed: 30653046]
ManciniF, CorsiA, De MaioF, RiminucciM, IppolitoE. Scoliosis and spine involvement in fibrous dysplasia of bone.Eur Spine J.2009;18:196-202. [PMC free article: PMC2899336] [PubMed: 19130098]
ManjilaS, ZenderCA, WeaverJ, RodgersM, CohenAR. Aneurysmal bone cyst within fibrous dysplasia of the anterior skull base: continued intracranial extension after endoscopic resections requiring craniofacial approach with free tissue transfer reconstruction.Childs Nerv Syst.2013;29:1183-92. [PubMed: 23435492]
MeierME, Hagelstein-RotmanM, van de VenAC, Van der GeestICM, DonkerO, PichardoSEC, Hissink MullerPCE, van der MeerenSW, DorleijnDMJ, WinterEM, van de SandeMAJ, Appelman-DijkstraNM. A multidisciplinary care pathway improves quality of life and reduces pain in patients with fibrous dysplasia/McCune-Albright syndrome: a multicenter prospective observational study.Orphanet J Rare Dis.2022;17:439. [PMC free article: PMC9758844] [PubMed: 36528764]
NarumiS, MatsuoK, IshiiT, TanahashiY, HasegawaT. Quantitative and sensitive detection of GNAS mutations causing McCune-Albright syndrome with next generation sequencing.PLoS One.2013;8:e60525. [PMC free article: PMC3607597] [PubMed: 23536913]
OvejeroD, LimYH, BoyceAM, GafniRI, McCarthyE, NguyenTA, EichenfieldLF, DeKlotzCM, GuthrieLC, TosiLL, ThorntonPS, ChoateKA, CollinsMT. Cutaneous skeletal hypophosphatemia syndrome: clinical spectrum, natural history, and treatment.Osteoporos Int.2016; 27:3615-26. [PMC free article: PMC6908308] [PubMed: 27497815]
PalmisanoB, SpicaE, RemoliC, LabellaR, Di FilippoA, DonsanteS, BiniF, RaimondoD, MarinozziF, BoydeA, RobeyP, CorsiA, RiminucciM.RANKL inhibition in fibrous dysplasia of bone: a preclinical study in a mouse model of the human disease.J Bone Miner Res.2019;34:2171-82. [PMC free article: PMC8408916] [PubMed: 31295366]
PanKS, FitzGibbonEJ, VitaleS, LeeJS, CollinsMT, BoyceAM. Utility of optical coherence tomography in the diagnosis and management of optic neuropathy in patients with fibrous dysplasia.J Bone Miner Res.2020;35:2199–210. [PubMed: 32644197]
PanKS, HeissJD, BrownSM, CollinsMT, BoyceAM. Chiari I malformation and basilar invagin*tion in fibrous dysplasia: prevalence, mechanisms, and clinical implications.J Bone Miner Res.2018;33:1990-8. [PMC free article: PMC6218312] [PubMed: 29924878]
ParvanescuA, CrosJ, RonotM, HenticO, GrybekV, CouvelardA, LevyP, ChansonP, RuszniewskiP, SauvanetA, GaujouxS.Lessons from McCune-Albright syndrome-associated intraductal papillary mucinous neoplasms: GNAS-activating mutations in pancreatic carcinogenesis.JAMA Surg.2014;149:858-62. [PubMed: 24898823]
PaulSM, GaborLR, RudzinskiS, GiovanniD, BoyceAM, KellyMR, CollinsMT. Disease severity and functional factors associated with walking performance in polyostotic fibrous dysplasia.Bone.2014;60:41-7. [PMC free article: PMC3985279] [PubMed: 24316419]
RabornLN, BurkeAB, EbbDH, CollinsMT, KabanLB, BoyceAM: Denosumab for craniofacial fibrous dysplasia: duration of efficacy and post-treatment effects.Osteoporos Int.2021;32:1889-93. [PubMed: 33772327]
RiminucciM, CollinsMT, FedarkoNS, ChermanN, CorsiA, WhiteKE, WaguespackS, GuptaA, HannonT, EconsMJ, BiancoP, Gehron RobeyP. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting.J Clin Invest.2003;112:683-92. [PMC free article: PMC182207] [PubMed: 12952917]
RobinsonC, BoyceAM, EstradaA, KleinerDE, MathewR, StantonR, FrangoulH, CollinsMT. Bone marrow failure and extramedullary hematopoiesis in McCune-Albright syndrome.Osteoporos Int.2018a;29:237-41 [PMC free article: PMC6983319] [PubMed: 29071359]
RobinsonC, EstradaA, ZaheerA, SinghVK, WolfgangCL, GogginsMG, HrubanRH, WoodLD, NoëM, MontgomeryEA, GuthrieLC, LennonAM, BoyceAM, CollinsMT. Clinical and radiographic gastrointestinal abnormalities in McCune-Albright syndrome.J Clin Endocrinol Metab.2018b;103:4293-303. [PMC free article: PMC6194803] [PubMed: 30124968]
RossDS, BurchHB, CooperDS, GreenleeMC, LaurbergP, MaiaAL, RivkeesSA, SamuelsM, SosaJA, StanMN, WalterMA. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis.Thyroid.2016;26:1343-1421. [PubMed: 27521067]
RoszkoKL, GuthrieL, LiX, CollinsMT, de CastroLF, BoyceAM. Identification of GNAS variants in circulating cell-free DNA from patients with fibrous dysplasia/McCune Albright syndrome.J Bone Miner Res.2023;38:443-50. [PubMed: 36593655]
RuggieriP, SimFH, BondJR, UnniKK. Malignancies in fibrous dysplasia.Cancer.1994;73:1411-24. [PubMed: 8111708]
SalenaveS, BoyceAM, CollinsMT, ChansonP. Acromegaly and McCune-Albright syndrome.J Clin Endocrinol Metab.2014;99:1955-69. [PMC free article: PMC4037730] [PubMed: 24517150]
SilvaES, LumbrosoS, MedinaM, GillerotY, SultanC, SokalEM. Demonstration of McCune-Albright mutations in the liver of children with high gammaGT progressive cholestasis.J Hepatol.2000;32:154-8. [PubMed: 10673080]
StantonRP, IppolitoE, SpringfieldD, LindamanL, WientroubS, LeetA. The surgical management of fibrous dysplasia of bone.Orphanet J Rare Dis.2012;7Suppl 1:S1. [PMC free article: PMC3359959] [PubMed: 22640754]
TanakaM, Fernández-del CastilloC, AdsayV, ChariS, FalconiM, JangJY, KimuraW, LevyP, PitmanMB, SchmidtCM, ShimizuM, WolfgangCL, YamaguchiK, YamaoK., et al.International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas.Pancreatology.2012;12:183-97. [PubMed: 22687371]
TanakaM, Fernández-Del CastilloC, KamisawaT, JangJY, LevyP, OhtsukaT, SalviaR, ShimizuY, TadaM, WolfgangCL. Revisions of international consensus f*ckuoka guidelines for the management of IPMN of the pancreas.Pancreatology.2017;17:738-53. [PubMed: 28735806]
TessarisD, CorriasA, MatarazzoP, De SanctisL, WasniewskaM, MessinaMF, VigoneMC, LalaR. Thyroid abnormalities in children and adolescents with McCune-Albright syndrome.Horm Res Paediatr.2012;78:151-7 [PubMed: 23006743]
van der BruggenW, VriensD, MeierME, SmitF, WinterEM, de Geus-OeiLF, Appelman-DijkstraNM. Denosumab reduces lesional fluoride skeletal burden on Na[18F]F PET-CT in patients with fibrous dysplasia/McCune-Albright syndrome.J Clin Endocrinol Metab.2021;106:e2980-e2994. [PMC free article: PMC8277209] [PubMed: 33788944]
VortmeyerAO, GläskerS, MehtaGU, Abu-AsabMS, SmithJH, ZhuangZ, CollinsMT, OldfieldEH. Somatic GNAS mutation causes widespread and diffuse pituitary disease in acromegalic patients with McCune-Albright syndrome.J Clin Endocrinol Metab.2012;97:2404-13. [PMC free article: PMC3791436] [PubMed: 22564667]
WangX, YuQ.Management of precocious puberty in girls with McCune-Albright syndrome using letrozole.Endocr Connect.2018;7:1424-31. [PMC free article: PMC6300860] [PubMed: 30475223]
WoodLD, NoëM, HackengW, BrosensLA, BhaijeeF, DebeljakM, YuJ, SuenagaM, SinghiAD, ZaheerA, BoyceA, RobinsonC, EshlemanJR, GogginsMG, HrubanRH, CollinsMT, LennonAM, MontgomeryEA. Patients with McCune-Albright syndrome have a broad spectrum of abnormalities in the gastrointestinal tract and pancreas.Virchows Arch.2017;470:391-400. [PMC free article: PMC5376511] [PubMed: 28188442]
WoodLD, ParsonsDW, JonesS, LinJ, SjöblomT, LearyRJ, ShenD, BocaSM, BarberT, PtakJ, SillimanN, SzaboS, DezsoZ, UstyankskyV, NikolskayaT, NikolskyY, KarchinR, WilsonPA, KaminkerJS, ZhangZ, CroshawR, WillisJ, DawsonD, ShipitsinM, WillsonJK, SukumarS, PolyakK, ParkBH, PethiyagodaCL, PantPV, BallingerDG, SparksAB, HartiganJ, SmithDR, SuhE, PapadopoulosN, BuckhaultsP, MarkowitzSD, ParmigianiG, KinzlerKW, VelculescuVE, VogelsteinB. The genomic landscapes of human breast and colorectal cancers.Science.2007;318:1108-13. [PubMed: 17932254]
XuD, LuW, WangX, WangJ, XieY, DongZ, WangW. Efficacy and safety of letrozole in treatment of McCune-Albright syndrome girls with peripheral precocious puberty.Zhejiang Da Xue Xue Bao Yi Xue Ban.2020;49:291-6. [PMC free article: PMC8800754] [PubMed: 32762164]
ZhadinaM, RoszkoKL, GeelsRES, de CastroLF, CollinsMT, BoyceAM. Genotype-phenotype correlation in fibrous dysplasia/McCune-Albright syndrome.J Clin Endocrinol Metab.2021;106:1482-90. [PMC free article: PMC8522305] [PubMed: 33512531]
